Medication overuse headache

Jan 31, 2020

Lilly's REYVOW(TM) (lasmiditan) C-V, the First and Only Medicine in a New Class of Acute Treatment for Migraine (ditan), Now Available for Prescription

Jul 23, 2019

Theranica: New Publication Compares Remote Electrical Neuromodulation for Acute Treatment of Migraine to Treatment with Acute Medications

Jul 09, 2019

Allergan Continues to Demonstrate Leadership in Migraine with 29 Presentations at the 2019 American Headache Society Annual Meeting

Jun 04, 2019

FDA Approves Emgality® (galcanezumab-gnlm) as the First and Only Medication for the Treatment of Episodic Cluster Headache that Reduces the Frequency of Attacks

Sep 27, 2018

Lilly's Emgality(TM) (galcanezumab-gnlm) Receives U.S. FDA Approval for the Preventive Treatment of Migraine in Adults

Jun 27, 2018

AHS 2018: Lilly Highlights Positive Phase 3 Results from the Largest Controlled Preventive Trial in Episodic Cluster Headache

Jan 24, 2018

Migraine Abortion Trial Shows Positive Results for Cefaly® Acute Medical Device

Jun 07, 2017

Promius Pharma to Present Innovative Scientific Results From Migraine Studies at the 59th Annual Scientific Meeting of the American Headache Society